Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aframomum danielli extract
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Aframomum danielli extract is a botanical research compound derived from the seeds of *Aframomum danielli*, a plant in the Zingiberaceae family. It contains a variety of bioactive phytochemicals, including long-chain polyprenyl benzoquinone derivatives (such as phytylplastoquinone), alkaloids, and polyphenols. Preclinical studies have demonstrated its potential as an anti-inflammatory agent through the inhibition of arachidonate 5-lipoxygenase. Additionally, it has shown inhibitory activity against alpha-amylase and alpha-glucosidase, suggesting potential applications in glycemic management and diabetes. Other research has explored its antimicrobial properties against pathogens like *Salmonella typhi* and its effects on sexual health via phosphodiesterase 5 (PDE5) and arginase inhibition. It is currently not in formal clinical development and has no known commercial sponsor.
- Other names
- Aframomum danielli extractA. danielli extractAframomum danielli K. Schum extract
02
Targets
AMY (Pancreatic alpha-amylase)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on aframomum danielli extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aframomum danielli extract.